A bipartisan majority of lawmakers have delivered a strong message to the Centers for Medicare & Medicaid Services: protect patients’ access to care and provide fair payment and more predictability for hospitals in regulations implementing “site-neutral” payment for new off-campus provider-based outpatient departments. Our thanks to four of our champions on this issue, Sens. Rob Portman, R-Ohio, and Charles Schumer, D-N.Y., and Reps. Devin Nunes, R-Calif., and Joseph Crowley, D-N.Y., for spearheading this effort. Their letters buttress hospitals’ arguments for more flexibility and a more accurate interpretation in how the agency applies those provisions from last year’s Bipartisan Budget Act. At the same time, we’re also pushing separate legislation – that has already passed the House – that would extend the effective date to grandfather new facilities that were under development to retain their existing provider-based status. We’ll keep pressing CMS to go back to the drawing board and come up with a fairer payment policy for 2017 or delay the regulations until it can….and, if necessary, seek relief from Congress post-election. Because the regulatory proposal will only exacerbate our challenges in providing the best possible care to patients and communities.

Related News Articles

The AHA today responded to an HHS request for input from health care providers and other stakeholders on ensuring legitimate access to controlled substances…
The Substance Abuse and Mental Health Services Administration today released a proposed rule that would amend federal regulations regarding disclosure of…
Two weeks ago, I wrote about the
Insights and Analysis
Robyn Begley, AHA senior vice president and chief nursing officer and CEO of the American Organization for Nursing Leadership, encourages hospital leaders to…
The U.S. Court of Appeals for the District of Columbia Circuit reversed the voiding of a rule that included Medicare and private insurance payments when…
John O’Brien will soon depart his position as senior advisor for drug pricing reform.